Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. operates a network of outpatient diagnostic imaging centers in the United States and provides professional radiology interpretation services. Its business combines owned imaging facilities with joint-venture partnerships with health systems, allowing it to perform scans, read imaging studies, and manage centers across multiple states.
Business
Share of revenueImaging studies performed at owned or controlled outpatient centers, including advanced modalities.
Interpretation of imaging studies performed by radiologists for hospitals and affiliated centers.
Fees earned for managing joint-venture imaging centers and related support services.
Customers
Lumexa Imaging serves patients referred for diagnostic imaging, but the economic customer is primarily the health system, hospital, physician network, or joint-venture partner that directs imaging volume into its centers. It also earns professional services revenue from interpreting studies performed by hospital imaging departments and from managing outpatient centers owned with health system partners.
Partner hospitals and health systems that co-own outpatient imaging centers and rely on Lumexa to manage day-to-day operations and capture imaging volume.
Patients receiving imaging studies at outpatient centers, typically through physician or hospital referral pathways.
Hospitals that use Lumexa radiologists to interpret imaging studies performed by the hospital's own imaging department.
Clinicians and medical groups that direct patients to Lumexa centers because of access, modality breadth, and local coverage.
Strategy
Lumexa Imaging's strategy centers on building density in outpatient imaging markets, expanding advanced imaging volume, and using health system partnerships to secure referral flow and local market access. The company also relies on a hybrid model of consolidated centers and unconsolidated joint ventures, which broadens reach while preserving operating influence.
MRI and CT are higher-value modalities and a larger share of revenue, so mix expansion supports the business model.
Joint ventures provide referral access, local credibility, and a route to expand outpatient center footprint.
A dense network of centers improves convenience for patients and supports scale economics across markets.
Geography
Lumexa Imaging is a U.S.-based business with its outpatient imaging footprint spanning 13 states. The company reported 189 centers as of March 31, 2026, making its geography important for referral density, hospital partnerships, and access to advanced imaging demand.
Risks
Lumexa Imaging depends on referral volume, utilization rates, and continued access to health system partners, so changes in patient flow or partner relationships can affect results. The business also faces healthcare regulatory, reimbursement, cybersecurity, and medical liability risks, while its joint-venture structure adds complexity to control, accounting, and cash distribution timing.
Revenue depends on patients being directed to Lumexa centers and on scan utilization across its footprint.
Exposure: Outpatient imaging centers and professional services
The company operates many centers through joint ventures and management contracts, so partner decisions matter to access and economics.
Exposure: Joint-venture outpatient imaging centers
Imaging economics are sensitive to payer rates, authorization requirements, and shifts between commercial and government payers.
Exposure: Diagnostic imaging and radiology services
The company handles protected health information, and the filing references an information incident and notification process.
Exposure: Patient records and operational systems
Medical imaging businesses are exposed to healthcare billing, privacy, and state/federal regulatory requirements.
Exposure: Healthcare operations and billing
Accounting
Judgemental items86 outpatient imaging centers were accounted for as unconsolidated affiliates, so earnings are shown net rather than fully consolidated.
Impact: Affects revenue presentation, EBITDA comparability, and cash flow interpretation
Fees are earned for operating JV centers, often based on a percentage of center net revenue.
Impact: Can move with center performance and ownership structure
Revenue is driven by imaging studies performed and interpreted, so timing follows service delivery and volume.
Impact: Quarterly results can vary with scan volume and modality mix
The company disclosed an information incident under evaluation for remediation and notification costs.
Impact: May require accruals or future expense recognition if liabilities become probable
Similar listed companies
Publicly listed companies with a comparable business focus.
RadNet, Inc.
RDNT · Services-Medical Laboratories
QT Imaging Holdings, Inc
QTI · Electromedical & Electrotherapeutic Apparatus
Nano-X Imaging Ltd.
NNOX · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Insight Molecular Diagnostics Inc.
IMDX · In Vitro & In Vivo Diagnostic Substances
Ocular Therapeutix, Inc
OCUL · Pharmaceutical Preparations
Varex Imaging Corp
VREX · Electronic Components, NEC
Varex Imaging Corp designs and manufactures X-ray imaging components and related systems used inside medical, security, and industrial inspection equipment.
Last updated: 24/09/2026